Clinical Trials Directory

Trials / Unknown

UnknownNCT03944044

Paracetamol Route in Palliative Care Patients (PARASCIVPALLIA)

Paracetamol Route in Palliative Care Patients : Intravenous Versus Subcutaneous Route Pharmacokinetics, Study Protocol for a Randomized Equivalence Pilot Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University Hospital, Caen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Background: Among palliative-care patients, subcutaneous route is often an alternative to intravenous route yet pharmacological and clinical data are lacking. Many French palliative crew are now using empirically paracetamol by subcutaneous route also there is no data to support this practice. The aim of the present study is to compare pharmacokinetics parameters between intravenous and subcutaneous route for palliative-care patients. Methods/design: A randomized, open, crossover, bicenter study in two palliative care centers. The aim is to demonstrate the pharmacokinetic equivalence between the two routes of administration. Data analysis will be performed by Wilcoxn's signed Rank Test with an alpha risk of 5 percent. All adverse events will be reported for a safety analysis. Discussion: This trial may permit, if a pharmacokinetic equivalence is established, to build randomized controlled trials to then assess the efficacy and tolerability of subcutaneous paracetamol administration.

Conditions

Interventions

TypeNameDescription
OTHERParacetamol route in palliative-care patients: intravenous versus subcutaneous route Pharmacokinetics study protocolCompare the pharmacokinetic (PK) of SC and intravenous (IV) routes in the same patient in a palliative care situation, to determine if there is a PK equivalence between these two modes of administration of Paracetamol.

Timeline

Start date
2019-07-15
Primary completion
2023-05-01
Completion
2024-03-01
First posted
2019-05-09
Last updated
2022-05-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03944044. Inclusion in this directory is not an endorsement.